Skip to main content
Caplight Logo









SeqOne

SeqOne

Private
MontpellierHealthcare & Life Scienceshttps://www.seqone.com/

Last Round

Growth Equity

May 22, 2022

Total Funding Raised

$48.7M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

SeqOne is a healthcare technology company that provides an AI-powered genomic analysis platform for personalized medicine.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical AI, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

genomic analysis platformNGS data analysisprecision medicinemedical AIclinical genomicsNGScancer genomicsrare disease genomicsbioinformatics platformCE-IVDvariant interpretationclinical decision supportLIMS integrationusage-based billingbioinformatics servicesEHR integration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SeqOne Comparables

Compare SeqOne with similar companies based on industry and business-model similarity.

SeqOne comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Limbus Medical Technologies
83%
Geneyx
81%
SOPHiA GENETICS
79%

SeqOne Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityMay 22, 2022
Series AJan 24, 2022
SeedMar 28, 2019

Key People

Founding team and executive leadership

Martin Dubuc

Chief Executive Officer

Executive Team

Peter Fox

Deputy Chief Technology Officer

Executive Team

Danaë Geraud

CFO COO

Executive Team

Alexander Kurze

Chief Operating Officer

Executive Team

SeqOne Investors

Notable investors and investment history

SeqOne investors
InvestorRounds
Elaia PartnersGrowth Equity, Series A, Seed
Supernova InvestGrowth Equity
Omnes CapitalGrowth Equity, Series A
IRDI Soridec GestionSeries A, Seed
BpifranceSeed
Mérieux Equity PartnersGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 78% MoM.

  • Jan 6, 2026

    Monthly visitors increased 58% MoM.

SeqOne Filings

Explore SEC and related filing metadata, where available.

SeqOne filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SeqOne's valuation, stock price, and market status.

Is SeqOne a public or private company?

SeqOne is a private company.

What is the current stock price of SeqOne?

SeqOne is a private company with no public stock price. No recent secondary market data is available.

How much is SeqOne worth (valuation)?

Valuation information for SeqOne is not publicly available.

Can I buy SeqOne stock?

SeqOne shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SeqOne's last funding round?

SeqOne's most recent funding round was Growth Equity on May 22, 2022.

Who are the main investors in SeqOne?

Key investors in SeqOne include Elaia Partners, Supernova Invest, Omnes Capital.

Will SeqOne IPO soon?

No public IPO plans have been announced for SeqOne.

How can I track SeqOne secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SeqOne's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontpellier
Employee Range107
Year Founded2017
Last FundingMay 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?